Christopher S. Coffey

2.5k total citations
26 papers, 1.4k citations indexed

About

Christopher S. Coffey is a scholar working on Psychiatry and Mental health, Surgery and Neurology. According to data from OpenAlex, Christopher S. Coffey has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Surgery and 5 papers in Neurology. Recurrent topics in Christopher S. Coffey's work include Migraine and Headache Studies (7 papers), Statistical Methods in Clinical Trials (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Christopher S. Coffey is often cited by papers focused on Migraine and Headache Studies (7 papers), Statistical Methods in Clinical Trials (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Christopher S. Coffey collaborates with scholars based in United States, United Kingdom and Italy. Christopher S. Coffey's co-authors include Karen L. Roos, Óscar H. Del Brutto, Héctor H. Garcı́a, Scott W. Powers, Leslie Korbee, Leigh A. Chamberlin, Andrew D. Hershey, Joseph A. Smith, Sam S. Chang and SAJAL C. DUTTA and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Neurology.

In The Last Decade

Christopher S. Coffey

24 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher S. Coffey United States 14 439 333 329 251 235 26 1.4k
Semra Akgöz Türkiye 16 216 0.5× 50 0.2× 187 0.6× 110 0.4× 135 0.6× 41 888
Cenker Eken Türkiye 21 367 0.8× 83 0.2× 119 0.4× 282 1.1× 82 0.3× 75 1.2k
William Camann United States 23 1.3k 2.9× 208 0.6× 157 0.5× 47 0.2× 320 1.4× 88 2.1k
Katharina M. Busl United States 19 145 0.3× 780 2.3× 112 0.3× 204 0.8× 55 0.2× 87 1.5k
Suhong Tong United States 21 494 1.1× 64 0.2× 116 0.4× 282 1.1× 29 0.1× 74 1.5k
Tania R. Gunn New Zealand 25 237 0.5× 234 0.7× 62 0.2× 747 3.0× 30 0.1× 69 3.5k
Zhanggang Xue China 21 339 0.8× 123 0.4× 75 0.2× 126 0.5× 74 0.3× 55 1.9k
Amit Chopra United States 22 204 0.5× 232 0.7× 158 0.5× 86 0.3× 57 0.2× 137 1.7k
Peter Wilmshurst United Kingdom 27 386 0.9× 399 1.2× 216 0.7× 417 1.7× 91 0.4× 92 2.6k
Sven Gottschling Germany 25 241 0.5× 77 0.2× 145 0.4× 86 0.3× 86 0.4× 81 1.3k

Countries citing papers authored by Christopher S. Coffey

Since Specialization
Citations

This map shows the geographic impact of Christopher S. Coffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Coffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Coffey more than expected).

Fields of papers citing papers by Christopher S. Coffey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Coffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Coffey. The network helps show where Christopher S. Coffey may publish in the future.

Co-authorship network of co-authors of Christopher S. Coffey

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Coffey. A scholar is included among the top collaborators of Christopher S. Coffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Coffey. Christopher S. Coffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Marek, Kenneth, David Russell, Luis Concha‐Marambio, et al.. (2025). Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study. EBioMedicine. 112. 105567–105567. 4 indexed citations
3.
Pierz, Kerri A., Whitley W. Aamodt, Caroline Gochanour, et al.. (2025). Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and older. npj Parkinson s Disease. 11(1). 280–280.
4.
Quigg, Mark, et al.. (2024). National Institute of Neurological Disorders and Stroke Clinical Trials Methodology Course. PubMed. 3(4). e200174–e200174.
5.
Leroux, Andrew, Ciprian M. Crainiceanu, Scott L. Zeger, et al.. (2024). Statistical modeling of acute and chronic pain patient-reported outcomes obtained from ecological momentary assessment. Pain. 165(9). 1955–1965. 4 indexed citations
6.
Brumm, Michael C., Kerri A. Pierz, David-Erick Lafontant, et al.. (2023). Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older. Neurology. 100(16). e1691–e1701. 25 indexed citations
7.
Gibler, Robert C., James Peugh, Christopher S. Coffey, et al.. (2023). Impact of preventive pill‐based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention ( CHAMP ) trial and a comparison of self‐report to nosology‐derived assessments. Headache The Journal of Head and Face Pain. 63(6). 805–812. 3 indexed citations
8.
Powers, Scott W., Christopher S. Coffey, Leigh A. Chamberlin, et al.. (2021). Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial. JAMA Network Open. 4(7). e2114712–e2114712. 14 indexed citations
9.
Peugh, James, Andrew D. Hershey, Christopher S. Coffey, et al.. (2021). Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial. Cephalalgia. 42(1). 44–52. 5 indexed citations
10.
Irwin, David J., Christopher S. Coffey, Chelsea Caspell‐Garcia, et al.. (2020). Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Annals of Neurology. 88(3). 574–587. 57 indexed citations
11.
Powers, Scott W., Christopher S. Coffey, Leigh A. Chamberlin, et al.. (2016). Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. New England Journal of Medicine. 376(2). 115–124. 224 indexed citations
12.
Powers, Scott W., Andrew D. Hershey, Christopher S. Coffey, et al.. (2016). The Childhood and Adolescent Migraine Prevention (CHAMP) Study: A Report on Baseline Characteristics of Participants. Headache The Journal of Head and Face Pain. 56(5). 859–870. 26 indexed citations
13.
Clifton, Guy L., Alex B. Valadka, David Zygun, et al.. (2010). Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. The Lancet Neurology. 10(2). 131–139. 322 indexed citations
14.
Gurka, Matthew J., Christopher S. Coffey, & Kelly K. Gurka. (2010). Internal pilots for observational studies. Biometrical Journal. 52(5). 590–603. 7 indexed citations
15.
Kairalla, John A., Keith E. Muller, & Christopher S. Coffey. (2010). Combining an Internal Pilot with an Interim Analysis for Single Degree of Freedom Tests. Communication in Statistics- Theory and Methods. 39(20). 3717–3738. 5 indexed citations
16.
Coffey, Christopher S. & John A. Kairalla. (2008). Adaptive Clinical Trials. Drugs in R&D. 9(4). 229–242. 48 indexed citations
17.
Brutto, Óscar H. Del, Karen L. Roos, Christopher S. Coffey, & Héctor H. Garcı́a. (2006). Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel. Annals of Internal Medicine. 145(1). 43–51. 154 indexed citations
18.
Coffey, Christopher S., Patricia R. Hebert, Marylyn D. Ritchie, et al.. (2004). An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene Interactions on risk of myocardial infarction: The importance of model validation. BMC Bioinformatics. 5(1). 49–49. 110 indexed citations
19.
Ellis, Shelley, Christopher S. Coffey, Edward F. Mitchel, Robert S. Dittus, & Marie R. Griffin. (2003). Influenza– and Respiratory Syncytial Virus–Associated Morbidity and Mortality in the Nursing Home Population. Journal of the American Geriatrics Society. 51(6). 761–767. 82 indexed citations
20.
DUTTA, SAJAL C., Sam S. Chang, Christopher S. Coffey, et al.. (2002). Health Related Quality of Life Assessment After Radical Cystectomy: Comparison of Ileal Conduit with Continent Orthotopic Neobladder. The Journal of Urology. 164–167. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026